Liu Xue-Chen, Wang Wei, Wang Lian-Yi
First Hospital of Tsinghua University, School of Clinical Medicine, Tsinghua University, Beijing 100016, China.
Heart Center, First Hospital of Tsinghua University, Beijing 100016, China.
World J Cardiol. 2024 Aug 26;16(8):491-495. doi: 10.4330/wjc.v16.i8.491.
Antiphospholipid syndrome (APS) is a chronic autoimmune disease characterized by venous or arterial thrombosis, pregnancy morbidity and a variety of other autoimmune and inflammatory complications. Here, we report a case of APS associated with multiple coronary thromboses.
The patient, a 28-year-old male, suffered from recurrent coronary thromboses over a period of 31 months. Despite undergoing interventional coronary procedures, thrombolytic therapy, and anticoagulation treatment, the condition persisted intermittently. An extensive search for underlying thrombogenic factors revealed a diagnosis of APS. Accurate adjustment of the medication regimen led to the absence of further acute coronary syndrome (ACS) episodes during the subsequent 20-month follow-up. Although the patient occasionally experiences chest tightness, no further symptoms of distress have been reported.
APS can manifest as ACS. Screening for rheumatologic and immunological conditions is essential when encountering patients with multiple coronary thromboses. Treatment strategy should include symptomatic relief and a targeted and aggressive approach to address the underlying pathophysiology.
抗磷脂综合征(APS)是一种慢性自身免疫性疾病,其特征为静脉或动脉血栓形成、妊娠并发症以及多种其他自身免疫和炎症并发症。在此,我们报告一例与多发性冠状动脉血栓形成相关的抗磷脂综合征病例。
该患者为一名28岁男性,在31个月的时间里反复发生冠状动脉血栓形成。尽管接受了冠状动脉介入手术、溶栓治疗和抗凝治疗,但病情仍间歇性持续。对潜在血栓形成因素进行广泛排查后确诊为抗磷脂综合征。准确调整药物治疗方案后,在随后20个月的随访期间未再出现急性冠状动脉综合征(ACS)发作。尽管患者偶尔仍会感到胸闷,但未报告进一步的不适症状。
抗磷脂综合征可表现为急性冠状动脉综合征。遇到多发性冠状动脉血栓形成的患者时,筛查风湿和免疫状况至关重要。治疗策略应包括缓解症状以及针对潜在病理生理机制采取有针对性的积极措施。